Investigators say finding the optimal heparin dose is important, although identifying that sweet spot remains elusive.

Experts have welcomed the idea of a new option for secondary stroke prevention, although cost could slow initial uptake.

These findings suggest cautious statin discontinuation in primary prevention only after shared decision-making,” Nicolas ...

MAR001 successfully lowered triglyceride levels in the phase IIa trial, but whether this reduces CV risk isn’t yet known.

The supervised intervention seemed to be durable, suggesting patients learned things that may help them in the long term.

An early stop of the OptimPacing trial may have exaggerated the benefits, but experts say many EPs have already made the ...

The drug failed to reduce CV events in the RCT, but it’s clear many still hold out hope for the inflammatory hypothesis.

Patients had fewer MACE over 4 years compared with a standard systolic target, but some had worsened renal function.

One trial does not disprove the concept that lowering Lp(a) can reduce CV risk, Steven Nissen stresses, with “more work to do ...

Using previously obtained CT scans, operators were able to plan procedures ahead of time, with no ill effects on outcome.

A “successful” procedure may have a different meaning to the heart team than to the patient, Misty Theriot stressed.

SAN DIEGO, CA—Patients treated with the Agent drug-coated balloon (DCB; Boston Scientific) have encouraging outcomes at 1 ...